Abstract
Background: Given recent increase in prevalence of oropharyngeal squamous cell carcinoma (OPSCC) and advances in surgical capabilities, we sought to determine whether a change in frequency of surgery-based treatment for locally advanced OPSCC has occurred. Methods: Patients with T3-T4b OPSCC in the National Cancer Database diagnosed from 2010 to 2016 were categorized as receiving primary surgery or radiation-based therapy and stratified by human papillomavirus (HPV) status. Trends in treatment selection and factors associated with treatment type were examined. Results: 6566 patients with HPV-positive were included, of whom 489 (7.45%) received surgery and 4698 patients with HPV-negative, of whom 362 (7.71%) received surgery. The percentage of patients treated with surgery decreased from 11.8% to 5.9% for HPV-positive disease and from 9.8% to 6.3% for HPV-negative disease. Factors associated with surgery included younger age, health insurance, and treatment at academic centers. Conclusions: In HPV-positive and HPV-negative disease, the percentage of locally advanced OPSCC undergoing surgery-based therapy has decreased.
Original language | English (US) |
---|---|
Pages (from-to) | 3476-3492 |
Number of pages | 17 |
Journal | Head and Neck |
Volume | 43 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2021 |
Keywords
- chemoradiation
- human papillomavirus
- oropharynx
- squamous cell carcinoma
- transoral robotic surgery
ASJC Scopus subject areas
- Otorhinolaryngology